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Abstract Acute decompensated heart failure is a common
reason for presentation to the emergency department and is
associated with high rates of admission to hospital. Distin-
guishing between higher-risk patients needing hospitalization
and lower-risk patients suitable for discharge home is impor-
tant to optimize both cost-effectiveness and clinical outcomes.
However, this can be challenging and few validated risk
stratification tools currently exist to help clinicians. Some
prognostic variables predict risks broadly in those who are
admitted or discharged from the emergency department. Risk
stratification methods such as the Emergency Heart Failure
Mortality Risk Grade and Acute Heart Failure Index clinical
decision support tools, which utilize many of these predictors,
have been found to be accurate in identifying low-risk
patients. The use of observation units may also be a cost-
effective adjunctive strategy that can assist in determining
disposition from the emergency department.
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Introduction: Significance of Acute Heart Failure
The initial clinical encounter for acute decompensated heart
failure (ADHF) often occurs in the emergency department
(ED), followed frequently by hospitalization. Heart failure
(HF) has become one of the leading reasons for hospitaliza-
tion with over 1.1 million hospital admissions for the con-
dition in the United States in 2006. The direct and indirect
costs of HF are estimated to be approximately $40 billion in
the United States alone [1].
The clinical course of HF patients who visit the ED is
characterized by repeat visits to the ED, hospital readmis-
sions, and high mortality [2–5]. United States Medicare data
reported that patients who were hospitalized for HF in
1999–2000 had a 50 % all-cause readmission rate, 20 %
HF readmission rate, and 31.4 % had died within 1 year [6].
Over 50 % of HF patients in this study revisited the ED
within 3 months of discharge [6].
An important decision that must be made in the ED is
whether to admit patients presenting with acute HF to an
inpatient unit or to discharge them home. At the present
time, these decisions are based primarily on clinical judge-
ment, and are not necessarily guided by prognostic guid-
ance. The variability in the results of clinical judgement is
reflected by the differences in the crude discharge rates of
HF patients from the ED. A multicenter study conducted in
20 hospitals in Spain showed an ED discharge rate of
32.7 % [7•]. Similarly, among patients diagnosed with acute
HF in an ED in Alberta, Canada, approximately one third of
these patients were not admitted to hospital [8]. Data from
the Peer Review Organization Voluntary hospital associa-
tion Initiative to Decrease Events (PROVIDE) for HF study
described higher admission rates in the participating United
States health care centers compared to the rates described in
Canada and Spain [9].
There are many potential reasons why the discharge rates
of ADHF patients to home from the ED may vary. These
include variations in clinical judgement, perceived standard
of care, local hospital or physician practice culture, potential
medical-legal ramifications, and regional patterns of hospital-
ization [10]. Because some of these factors are more
Curr Heart Fail Rep (2012) 9:252–259
DOI 10.1007/s11897-012-0100-1
# The Author(s) 2012. This article is published with open access at Springerlink.com
E. C. Ho :M. J. Schull :D. S. Lee (*)
Institute for Clinical Evaluative Sciences, Division of Cardiology,
University Health Network,
Room G-106, 2075 Bayview Avenue,
Toronto, ON M4N 3M5, Canada
e-mail: dlee@ices.on.ca
M. J. Schull
Sunnybrook and Institute for Clinical Evaluative Sciences, and the
Division of Emergency Medicine, Department of Medicine,
University of Toronto,
Toronto, Canada
modifiable than others, tools to assist with clinical decision-
making can potentially improve patient care. For example,
Smith et al. [11] found that based on clinical judgement alone,
physician estimation of the need for critical care management
in ADHF was inaccurate. In this case, there was overestima-
tion of the need for this level of care.
Prior studies have demonstrated the pitfalls of decision-
making based solely on clinical grounds in the ED. An analysis
of a population-based database of HF patients in Ontario,
Canada reported that there was substantial overlap in the pre-
dicted mortality risks of HF patients who were discharged from
the ED or admitted to hospital [12••]. Specifically, some
patients who were discharged were at higher risk of 7-day
death, while conversely, many hospitalized patients were low
risk. When those with similar predicted risks of death were
compared, those who were discharged had a higher observed
risk of 90-day mortality. In the absence of clinical risk stratifi-
cation to guide admission-discharge decisions, others have
demonstrated that indiscriminate hospitalization of HF patients
does not lead to a reduction inmortality or repeat ED visits [7•].
Ideally, patients who are low risk could be considered for
discharge home without immediate hospitalization if they
improve symptomatically. However, many low-risk patients
are admitted to hospital because decision support methods
that provide prognostic guidance have not been available.
Hospitalizations and hospital readmissions are major con-
tributors to the costs of HF care. Being better able to decide
upon who needs hospital admission or can be discharged
home may lead to improved utilization of health care resour-
ces and decreased costs. However, doing so will require that
those who are discharged from the ED are provided rapid
and appropriate follow-up care.
Studies of those who were discharged from the ED sug-
gest that patients may return for acute medical care if a
systematic approach to post-discharge follow-up care is
not enabled. In one report, 61 % of patients discharged
home from the ED with a diagnosis of ADHF experienced
failure of outpatient therapy within 90 days. The median
time to failure of therapy (defined as recurrent presentation
with ADHF, hospitalization for ADHF or death) was 30 days
[13]. Another study from Alberta, Canada found a signifi-
cantly increased rate of repeat visits to the ED at 30 days and
1 year among those HF patients who were discharged home
from the ED compared to those who were admitted [8]. In
addition, the authors found that the all-cause mortality rate
was also significantly lower in the admitted group.
While the optimal model of acute HF follow-up care has not
been determined, early physician collaboration is an important
component of the care regimen [14••]. In a propensity-matched
study of patients who were discharged from the ED, those who
received early collaborative care by a cardiac specialist and a
primary care provider had substantially reduced mortality com-
pared to those who were assessed by either type of physician
alone [14••]. The risk of the composite of death, repeat ED
visits, or hospitalization for any cause, was similarly reduced
among those with collaborative care [14••]. Notably, the first
physician visit occurred a median of 3 days post-discharge and
75%of patients were seenwithin 7 days among those receiving
collaborative care. In contrast, the first physician visit occurred
a median of 5 days (75 % within 12 days) in the primary care
only and a median of 9 days (75 % within 18 days) after the
index ED discharge in the cardiology only groups. Uniformly,
the worst outcomes were observed among those who were not
assessed by either type of physician within 30 days.
Prognostic Factors of HF Patients in the ED Setting
Although the ED is frequently the point of initial hospital
contact of patients with acute HF, the ED has not been
widely considered as an inception point from the standpoint
of clinical registries. As a consequence, there is a paucity of
evidence that can be readily translated to the care of acute
HF patients in the ED. We identified few studies conducted
in the ED setting; however, these examined the partial group
of patients who were discharged without hospital admission.
Rame et al. [13] examined patients who were discharged
home directly from the ED after presenting with ADHF, but
then failed outpatient therapy within 90 days of discharge.
In their analysis, the only predictor of outpatient treatment
failure was increased respiratory rate at presentation. Miro et
al. [7•] examined 259 patients and found that functional
impairment was a predictor of recurrent presentation with
ADHF within 30 days of discharge from the ED. They also
found that a history of hypertension and systolic blood
pressure greater than 160 mmHg on arrival predicted a
decreased risk of return to the ED. In a retrospective analysis
of 385 patients, Burkhardt et al. [15] found that blood urea
nitrogen level over 30 mg/dL was the only factor that was
associated with an increased risk of hospital admission.
In sum, there are few studies of HF patients who are dis-
charged from the ED, and the majority of previously performed
studies have been small. Prognostic factors from these small
studies differ, and these individual prognostic factors are insuf-
ficiently sensitive or specific to guide clinical decision making.
A unifying risk model for the broad range of acute HF patients
presenting to the ED that incorporates the most important
prognostic factors is potentially useful for guiding care.
Extrapolating from Risk Stratification Models
for Admitted Patients
While the prognostic factors predicting adverse outcomes
among the broad spectrum of HF patients presenting to the
ED have not been determined, partial insights may be
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obtained by examining the generally higher risk cohorts who
have been admitted to hospital. There have been several risk
stratification methods developed for hospitalized cohorts.
The Enhanced Feedback for Effective Cardiac Treatment
(EFFECT) study investigators found that the predictors of 30-
day mortality after admission for ADHF included older age,
lower systolic blood pressure, higher respiratory rate, higher
blood urea nitrogen level, and hyponatremia [16]. Subsequent-
ly published reports from the Outcomes of a Prospective Trial
of Intravenous Milrinone for Exacerbations of Chronic Heart
Failure (OPTIME-CHF) [17], the Acute Decompensated Heart
Failure National Registry (ADHERE) [18], and others [19],
have all confirmed the prognostic importance of systolic blood
pressure, blood urea nitrogen and/or serum creatinine concen-
tration, and hyponatremia for death occurring in hospital to
60 days after presentation. Additional predictors of mortality
included NewYork Heart Association class IV symptoms [17],
reduced ejection fraction, and low hemoglobin at admission
[20], which were strong predictors of all-cause mortality from
30 to 60 days after HF presentation.
The challenge of identifying low-risk HF patients in the
ED setting was exemplified by Chin and Goldman [21] who
found that low initial blood pressure, high initial respiratory
rate, hyponatremia, and new ST-T wave changes on the 12-
lead electrocardiogram were associated with poor prognosis.
However, the challenge of identifying low-risk HF patients
in the ED setting was recognized because absence of the
above factors did not identify a true low-risk group, since
the rate of death or major complications was 6 % in the lowest
risk group during the hospital stay [21]. The ADHERE clas-
sification and regression tree analysis identified a lower-risk
group; however, in-hospital mortality still exceeded 2% in the
lowest-risk group, which may be unacceptably high for de-
ciding who is safe to discharge home in the ED setting [18].
Stratification of Risk among All Patients with ADHF
in the ED
Few studies have been designed specifically to identify low-
risk ED patients with ADHF. However, a risk stratification
method that can identify low-risk patients may be of great
value in the ED setting because low-risk patients could
potentially be discharged home without hospital admission.
In this section, we describe some of the published methods
for acute HF risk stratification (Table 1).
Authors of the PROVIDE for HF study examined the
association between components of the Agency for Health
Care Policy and Research HF hospital admission criteria and
rates of admission and mortality [9]. Presence of pulmonary
edema, hypoxia not due to pulmonary disease, edema, and
symptomatic hypotension or syncope were associated with
increased probability of admission, longer duration of
hospital stay, and 30-day mortality. While admitted patients
did indeed have a higher mortality rate, it is important to
note that this study found that clinical judgement was not
always able to correctly distinguish patients at higher or
lower risk of death, especially as the number of admission
criteria increased [9]. The importance of acute respiratory
status was affirmed by the examination of a nurse-rated
triage acuity score that was objectively related to oxygena-
tion status in a population-based study of 68,380 HF
patients who visited the ED [22]. In this study, among those
with triage categories that roughly corresponded to initial
oxygen saturations below 90 %, 90 %–92 %, 93 %–95 %,
and above 95 %, the associated 7-day mortality rates were
17.2 %, 5.9 %, 3.8 %, and 2.5 %, respectively [22].
Society of Chest Pain Recommendations
Based on a review of the literature, the Society of Chest Pain
published guidelines that are applicable to HF, which included
a summary of high-risk features common to previously pub-
lished risk stratification tools. The common high risk features
were identified as low systolic blood pressure, renal impair-
ment, hyponatremia, ischemic changes on electrocardiogram
(ECG), and positive troponin. The society was careful to note
that absence of high-risk features should not be interpreted as
low risk without further investigation [23].
In a subsequent study, an external retrospective validation
was performed using data from the multinational heart failure
and Audicor technology (Inovise Medical, inc., Beaverton,
OR) for rapid diagnosis and initial treatment (HEARD-IT)
study [24•]. Using the guideline-based risk criteria, 20.2 % of
the cohort was defined as non–high risk because they did not
exhibit any high-risk features on presentation. The non–high
risk group exhibited a 0.5 % mortality rate and 12.4 % cardiac
event rate, and of the latter most were 30-day readmissions for
HF. While those with high-risk features had a 14.8 % overall
cardiac event rate (of which 5.7 % were deaths), there was no
significant difference in event rates between the high-risk and
non–high risk groups [24•].
Acute Heart Failure Index
The acute heart failure index (AHFI) was developed to
identify admitted HF patients at low risk of mortality or
serious inpatient adverse events [25]. A tree-based model
comprising 21 different factors incorporating demographic,
historical, vital sign, laboratory, electrocardiographic, and
radiographic components was developed. These variables
include arterial pH, diabetes, respiratory rate, pulmonary
congestion on chest imaging, pulse rate, creatinine concen-
tration, ECG evidence of myocardial ischemia, ECG evi-
dence of myocardial infarction, blood urea nitrogen, sodium
concentration, history of percutaneous coronary intervention
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(PCI), white blood count, glucose concentration, history of
angina, history of myocardial infarction, sex, potassium
concentration, temperature, systolic blood pressure, history
of chronic lung disease, and pleural effusion. The algorithm
requires knowledge of the most extreme value of the pre-
dictor variable on the day before or the day of admission for
risk determination. This tool identified a low-risk group
comprising 17.2 % of the derivation cohort that had rates
of 0.3 % for inpatient mortality and 1 % risk of serious
medical complications during admission.
A validation phase involving a retrospective population of
8,384 patients subsequently identified 19.2% of these patients
as low risk with an inpatient mortality rate of 0.7 %, rate of
serious medical complication during admission of 1.7 %, and
a 30-day mortality rate of 2.9 % [26]. A prospective validation
cohort study was recently published, demonstrating similar
results, with a rate of primary outcome events of 1.7 % occur-
ring in 23 % of the overall cohort who met low-risk criteria
[27•]. While the AHFI has been well-validated in cohorts who
have already been admitted to hospital, it has not been widely
studied in a broad range of HF patients, including those who
have been discharged from the hospital.
Emergency Heart Failure Mortality Risk Grade
The Emergency Heart Failure Mortality Risk Grade
(EHMRG) is unique compared to other validated risk pre-
diction models because it was derived in a broad cohort of
Table 1 Emergency depart-
ment–based prognostic factors
for acute HF
HF heart failure; AHFI Acute
Heart Failure Index; SCP
Society of Chest Pain; AHCPR
Agency for Health Care Policy
and Research; EHMRG Emer-





diogram; CXR Chest x-ray
AHFI SCP AHCPR EHMRG
Age x
Female x
Systolic blood pressure x x x x
Oxygen saturation x x
Heart rate x x





Creatinine/worsening renal function x x x
Blood urea nitrogen x x
Sodium x x
White blood count x
Glucose x
Metolazone at home x
Active Cancer x





Chronic lung disease x
Significant peripheral edema x
Recent onset HF x
Concomitant acute medical illness x
Failure of outpatient management x
Altered mentation
Significant arrhythmia
ECG evidence of ischemia x x x
Arterial blood gas pH x
CXR: Pleural effusion x
CXR: Pulmonary congestion/edema x x
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patients with ADHF presenting to the ED who were either
discharged home or admitted to the hospital [28••]. The score
was derived and validated in a cohort of 12,591 HF patients
who were not palliative and presented to one of 86 EDs in a
population-based study. The primary outcome was 7-day
mortality, which is temporally close to the acute HF visit,
and therefore clearly of importance to the physician in the
ED. Prior studies have found that mortality amongHF patients
is primarily cardiovascular [29, 30], and therefore deaths will
often be related to the cardiovascular disease with which the
patients presented at the index ED visit.
The score combines age, systolic blood pressure, heart
rate, oxygen saturation, serum creatinine, serum potassium,
serum troponin, presence of active cancer, current use of
metolazone, and mode of arrival to the ED to estimate 7-day
mortality after presenting to the ED with ADHF (Fig. 1).
Dividing patients into quintiles of risk based on the
EHMRG, the 7-day mortality rates were 0.3 % in the two
lowest risk quintiles. The highest-risk quintile was further
stratified into two groups corresponding to the highest two
deciles of risk, with mortality rates of 3.5 % and 8.2 % at
7 days. Among those who were discharged, the odds ratios
for death were greater than eightfold and 21-fold in the two
highest risk groups compared to the two lowest risk quan-
tiles combined. Similarly, the odds ratios for admitted
patients were greater than ninefold and 23-fold in the high-
est two risk groups compared to the lowest two risk quan-
tiles combined. There was an exceedingly low 7-day
mortality rate of 0.2 % among those in the lowest two risk
quantiles who were discharged from the ED, suggesting that
risks may be further reduced if coupled with clinical judge-
ment. Because the EHMRG incorporates information read-
ily available to clinicians in the ED and is applicable to all
patients with ADHF even before a disposition decision is
made, the EHMRG score will likely be a helpful tool for the
initial assessment of these patients (web calculator available
at www.ccort.ca).
Observation Units
Hospitals in various countries have integrated observation
units into their EDs as an alternative to inpatient ward
admission or direct discharge home. Common diagnoses in
these units include chest pain, syncope, atrial fibrillation,
asthma, and transient ischemic attacks. Patients moved to
the observation unit typically remain under the care of staff
from the ED with the goal of discharge home after a longer
time of observed management. Implementation of such a
unit in EDs varies by country. About one third of hospitals
in the United States had dedicated observation units in
2007–2008 [31], but the proportion of hospitals with obser-
vation units in most other countries has not been reported.
Data from a tertiary care teaching hospital showed that
implementation of an observation unit admission and treat-
ment protocol for ADHF reduced rate of return to the ED
with ADHF, mortality rate, and admissions to both the
observation unit and inpatient unit for ADHF at 90 days
[32]. It has since been suggested that a specialized HF
observation unit may be best for patient care while reducing
admission rates for ADHF [32]. However, others have
reported that outcomes of 30-day readmission and recurrent
ED visits for ADHF or mortality were similar when patients
managed in an observation unit were compared to those who
were hospitalized directly from the ED [33].
It has been found that observation units provide a cost-
effective alternative compared to hospital admission for
those with non–high risk HF [34••]. In the base case, com-
pared to an ED discharge strategy, hospitalization had a very
high marginal cost-effectiveness ratio of $684,101 per
quality-adjusted life year, whereas observation unit admis-
sion exhibited a reasonable cost-effectiveness ratio of
$44,249 per quality-adjusted life year [34••]. However, the
cost-effectiveness of observation units is dependent on base-
line risk, because with increasing risk of readmission or
post-discharge adverse events, it becomes more cost-
effective to admit to hospital, again emphasizing the impor-
tance of accurate risk stratification in the ED [34••]. Obser-
vation units also may represent an opportunity to better
assess the functional capacity of patients, which may further
assist in making clinical decisions, and determining the need
for home supports for patients who are planned for dis-
charge home [35].
A potential challenge is that not all HF patients are
suitable candidates for management in an observation unit.
Indeed, approximately 20 % of unselected patients who are
Fig. 1 Variables comprising
the EHMRG. EMS emergency
medical services; HR heart rate;
SBP systolic blood pressure
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managed in observation units are eventually admitted to the
hospital [36, 37]. Low-risk patients who are being consid-
ered for discharge home are likely the best candidates for
observation unit management. Diercks et al. [38] conducted
a prospective study of a convenience sample of almost 500
patients with a diagnosis of ADHF in the ED. They defined
low-risk patients by a length of stay less than 24 h and no
adverse events of death, myocardial infarction, arrhythmia,
or rehospitalization within 30 days. The low-risk group was
found to have a systolic blood pressure greater than
160 mmHg and a normal serum troponin [38]. Prognostic
risk algorithms for acute HF may better assist in the selec-
tion of low-risk patients for observation unit–based care
because prior data suggest that many HF admissions may
not be avoided by the nonselective use of observation units
[36, 37].
An Approach to Using EHMRG in Clinical Practice
The precise role of the observation unit for different catego-
rizations of the EHMRG has not been fully defined. The
EHMRG risk algorithm [28••] could be adapted for use in
conjunction with observation units, clinical decision units, or
short-stay hospital beds, as proposed in Fig. 2. In the absence
of extenuating circumstances, those with a high-risk EHMRG
score should be admitted to hospital. Intermediate-risk patients
who do not improve symptomatically should be admitted, and
conversely, those who improve could be considered for dis-
charge. Admission to the observation unit or a short-stay
hospitalization may be potential options for intermediate-risk
patients in whom the discharge disposition is not clear. Low-
risk patients who were administered therapy in the ED should
be reassessed for symptomatic improvement. However, low-
risk patients who did not require any therapy could be consid-
ered for direct discharge from the emergency discharge.
Conclusions
As the burden of HF increases worldwide, the EDwill become
an increasingly important focal point. As the gatekeeper of
hospital-based resources, decisions made in the ED setting are
also of critical importance. Indiscriminate hospitalization of
the majority of HF patients, including those who are low risk,
will have major fiscal implications that may not be sustain-
able. Hospital resources should be utilized to a greater extent
for higher-risk patients, while lower-risk patients who are
dischargeable could ideally be managed during the transition-
al phase via rapid outpatient care programs. The availability of
validated risk stratification tools will be instrumental in aiding
clinicians’ decision-making in this regard.
Risk stratification tools will likely operate in a comple-
mentary way with other management strategies, such as
observation units and rapid follow-up cardiac clinics that
can assess HF patients who have been recently discharged
from the ED. Finally, it is conceivable that future studies
may be able to deconstruct the key benefits of hospital-
based care. For example, hospitalized patients experience
more rapid assessment of left ventricular function and more
Fig. 2 Using the EHMRG.
EHMRG Emergency Heart
Failure Mortality Risk Grade;
ED emergency department
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careful titration and management of medications. If these
important processes of care can be provided rapidly and
routinely to patients after ED discharge, the threshold of
risk for deciding which HF patient may benefit from hospi-
tal admission or discharge home may be altered. The use of
risk stratification methods and novel models of early ambu-
latory care delivery may substantially improve the efficien-
cy of medical care of patients with acute HF syndromes
while optimizing utilization of health care resources.
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